drugset / Trial / NCT03829683
Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis
Phase 2
Completed
20 enrolled
Virginia Commonwealth University
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this research study is to test the safety, tolerability, and effectiveness of Vitamin C (ascorbic acid) intravenous infusion when used to treat alcoholic hepatitis (inflammation of the liver from heavy alcohol use) and sepsis (life-threatening complication of an infection).
Timeline
- Start
- 2019-04-16
- Primary completion
- 2022-03-31
- Completion
- 2022-06-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Vitamin C | Other / unclassified | 200 mg/kg | Intravenous |